755 related articles for article (PubMed ID: 15751057)
1. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.
Ravelli A; Felici E; Magni-Manzoni S; Pistorio A; Novarini C; Bozzola E; Viola S; Martini A
Arthritis Rheum; 2005 Mar; 52(3):826-32. PubMed ID: 15751057
[TBL] [Abstract][Full Text] [Related]
2. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis.
Ravelli A; Varnier GC; Oliveira S; Castell E; Arguedas O; Magnani A; Pistorio A; Ruperto N; Magni-Manzoni S; Galasso R; Lattanzi B; Dalprà S; Battagliese A; Verazza S; Allegra M; Martini A
Arthritis Rheum; 2011 Jan; 63(1):267-75. PubMed ID: 20936630
[TBL] [Abstract][Full Text] [Related]
3. Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis.
Felici E; Novarini C; Magni-Manzoni S; Pistorio A; Magnani A; Bozzola E; Buoncompagni A; Martini A; Ravelli A
J Rheumatol; 2005 Sep; 32(9):1805-10. PubMed ID: 16142881
[TBL] [Abstract][Full Text] [Related]
4. Antinuclear antibody-positive cohort constitutes homogeneous entity in juvenile idiopathic arthritis.
Ma X; Xin L; Sun J; Liu Z
Mod Rheumatol; 2016; 26(1):75-9. PubMed ID: 26025435
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish children.
Merino R; De Inocencio J; García-Consuegra J
J Rheumatol; 2001 Dec; 28(12):2731-6. PubMed ID: 11764225
[TBL] [Abstract][Full Text] [Related]
6. Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study.
Kunjir V; Venugopalan A; Chopra A
J Rheumatol; 2010 Aug; 37(8):1756-62. PubMed ID: 20516021
[TBL] [Abstract][Full Text] [Related]
7. Uveitis and anti nuclear antibody positivity in children with juvenile idiopathic arthritis.
Kasapçopur O; Yologlu N; Ozyazgan Y; Ercan G; Caliskan S; Sever L; Ozdogan H; Arisoy N
Indian Pediatr; 2004 Oct; 41(10):1035-9. PubMed ID: 15523130
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria.
Shin JI; Kim KH; Chun JK; Lee TJ; Kim KJ; Kim HS; Kim DS
Scand J Rheumatol; 2008; 37(5):348-51. PubMed ID: 18666025
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001).
Merino R; de Inocencio J; García-Consuegra J
J Rheumatol; 2005 Mar; 32(3):559-61. PubMed ID: 15742453
[TBL] [Abstract][Full Text] [Related]
10. Extended oligoarthritis and other risk factors for developing JIA-associated uveitis under ILAR classification and its implication for current screening guideline.
Sim KT; Venning HE; Barrett S; Gregson RM; Amoaku WM
Ocul Immunol Inflamm; 2006 Dec; 14(6):353-7. PubMed ID: 17162606
[TBL] [Abstract][Full Text] [Related]
11. Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis.
Tsitsami E; Bozzola E; Magni-Manzoni S; Viola S; Pistorio A; Ruperto N; Martini A; Ravelli A
Arthritis Rheum; 2003 Aug; 49(4):488-93. PubMed ID: 12910554
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of juvenile idiopathic arthritis in Alsace, France.
Danner S; Sordet C; Terzic J; Donato L; Velten M; Fischbach M; Sibilia J
J Rheumatol; 2006 Jul; 33(7):1377-81. PubMed ID: 16821272
[TBL] [Abstract][Full Text] [Related]
13. Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they?
Butbul YA; Tyrrell PN; Schneider R; Dhillon S; Feldman BM; Laxer RM; Saurenmann RK; Spiegel L; Cameron B; Tse SM; Silverman ED
J Rheumatol; 2009 Sep; 36(9):2033-41. PubMed ID: 19648305
[TBL] [Abstract][Full Text] [Related]
14. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
Habib HM; Mosaad YM; Youssef HM
Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the ILAR criteria for juvenile idiopathic arthritis.
Krumrey-Langkammerer M; Häfner R
J Rheumatol; 2001 Nov; 28(11):2544-7. PubMed ID: 11708431
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines.
Heiligenhaus A; Niewerth M; Ganser G; Heinz C; Minden K;
Rheumatology (Oxford); 2007 Jun; 46(6):1015-9. PubMed ID: 17403710
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease.
Grassi A; Corona F; Casellato A; Carnelli V; Bardare M
J Rheumatol; 2007 May; 34(5):1139-45. PubMed ID: 17343317
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis.
Saurenmann RK; Levin AV; Feldman BM; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2010 Jun; 62(6):1824-8. PubMed ID: 20178126
[TBL] [Abstract][Full Text] [Related]
19. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
Dewint P; Hoffman IE; Rogge S; Joos R; Union A; Dehoorne J; Delanghe J; Veys EM; De Keyser F; Elewaut D
Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of Wallace criteria for clinical remission in juvenile idiopathic arthritis: a cohort study of 761 consecutive cases.
Lurati A; Salmaso A; Gerloni V; Gattinara M; Fantini F
J Rheumatol; 2009 Jul; 36(7):1532-5. PubMed ID: 19487265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
